Ivana Vojnovic
- Pharmacology top 0.5%
- Biochemistry top 2%
- Cardiology and Cardiovascular Medicine top 10%
- Surgery
- Physiology top 10%
- Co-authors
- Timothy D. WarnerJane A. MitchellFrancesco GiulianoJohn R. VaneAntoaneta BukasaRut Lucas-DomínguezDavid Bishop‐BaileyRosario Jiménez
- Topics
- Inflammatory mediators and NSAID effects (11 papers)Antiplatelet Therapy and Cardiovascular Diseases (7 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
- Cited by
- PharmacologyBiochemistry
- Journals
- Proceedings of the National Academy of SciencesThe FASEB JournalJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Ivana Vojnovic
17 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Pharmacology 1.2k
- Biochemistry 290
- Cardiology and Cardiovascular Medicine 280
- Surgery 273
- Physiology 270
Countries citing papers authored by Ivana Vojnovic
This map shows the geographic impact of Ivana Vojnovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Vojnovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Vojnovic more than expected).
Fields of papers citing papers by Ivana Vojnovic
This network shows the impact of papers produced by Ivana Vojnovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Vojnovic. The network helps show where Ivana Vojnovic may publish in the future.
Co-authorship network of co-authors of Ivana Vojnovic
This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Vojnovic. A scholar is included among the top collaborators of Ivana Vojnovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Vojnovic. Ivana Vojnovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 24 | |
| 3 | 44 | |
| 4 | 24 | |
| 5 | 57 | |
| 6 | 38 | |
| 7 | 7 | |
| 8 | 60 | |
| 9 | 46 | |
| 10 | 92 | |
| 11 | 12 | |
| 12 | 41 | |
| 13 | 23 | |
| 14 | 37 | |
| 15 | 45 | |
| 16 | 68 | |
| 17 | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisbreakdown → | 1260 |
About Ivana Vojnovic
Ivana Vojnovic is a scholar working on Internal Medicine, Pharmacology and Biochemistry, having authored 17 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Pharmacology (1.2k citations), Biochemistry (290 citations) and Pharmacology (209 citations). Ivana Vojnovic has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Timothy D. Warner, Jane A. Mitchell, Francesco Giuliano, John R. Vane, Antoaneta Bukasa, Rut Lucas-Domínguez, David Bishop‐Bailey, Rosario Jiménez, Paul C. Armstrong and John Pepper. Their work appears in journals such as Proceedings of the National Academy of Sciences, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.